MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 60 - per page Next page
Order by
Amphora/ACIDFORM Microbicide
pH maintenance, Spermicide, Microbicide Lubricant More
Universally Applicable Technology for Inactivation of Enveloped Viruses and Other Pathogenic Microorganisms for Vaccine Development
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Biocompatible and biodegradable nanoparticles
Biocompatible and biodegradable nanoparticles designed to encapsulate drug allowing for its absorption and delivery More
Multiplex Microarray for Simultaneous Detection of Hepatitis C Virus, Hepatitis B Virus, and Human Immunodeficiency Virus Type-1
Specific and sensitive microarray and multiplex assay for the simultaneous detection and discrimination of HCV, HBV, and HIV-1, which include both RNA and DNA genomes. More
HIV-1 Gag monoclonal antibodies
Hybridomas (5 clones) expressing antibodies to human immunodeficiency virus type 1 More
Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use
Invention can be developed as an inhibitor therapeutically or prophylactically against retroviral and non-retroviral infections, and can be used in combination with other anti-viral agents to treat patients who have drug-resistant virus. More
HIV-1 integrase monoclonal antibodies
Hybridomas (2 clones) expressing antibodies to human immunodeficiency virus type 1 More
Broad Spectrum Antiviral Compounds
Broad spectrum antiviral compounds for treatment of infection caused by enveloped viruses More
HIV Entry Inhibitor
A chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity More
Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers
These compounds inhibit the deubiquitination of proteins by targeting the deubiquitination enzymes in the protein degradation pathway. More
Displaying 1..10 of 60 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us